Join UCLA oncologist Monica Mead, MD, for an overview of treatment options for patients diagnosed with diffuse large B-cell lymphoma (DLBCL) and other follicular lymphomas. DLBCL is the most common type of non-Hodgkin lymphoma (NHL) in the US, accounting for about 1 out of every 3 lymphomas.
Closer to a Cure Community Lecture Series
With recent advances in the treatments of blood cancers, UCLA Health and the Leukemia & Lymphoma Society are visiting communities across Southern California to discuss these emerging therapies.
Learn more about the Closer to a Cure Community Lecture Series
